REGENEMED

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.
REGENEMED
Industry:
Biotechnology Health Care
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.regenemed.com
Total Employee:
11+
Status:
Active
Contact:
8582009531
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
SPF LetsEncrypt Apache Google Maps HostPapa DNS
Similar Organizations
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Investors List
Tech Coast Angels
Tech Coast Angels investment in Venture Round - RegeneMed
Tech Coast Angels
Tech Coast Angels investment in Venture Round - RegeneMed
Official Site Inspections
http://www.regenemed.com
- Host name: 204.44.202.26
- IP address: 204.44.202.26
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto

More informations about "RegeneMed"
RegeneMed - Crunchbase Company Profile & Funding
RegeneMed accelerates the development of safer, more effective drugs by โฆSee details»
RegeneMed Inc. - Investors
RegeneMed is a privately held company incorporated in the State of California in 2003. The company was founded by the Co-Founder of Advanced Tissue Sciences (ATS) and the Lead โฆSee details»
RegeneMed 2025 Company Profile: Valuation, Funding โฆ
RegeneMed General Information Description. Operator of a biotechnology company intended to offer engineered human tissue-based assays. The โฆSee details»
REGENEMED, INC.: Contact Details and Business Profile
REGENEMED, INC. is a Biotechnology, Business Services General, and Health Care company_reader located in San Diego, California with $2 million in revenue and 4 employees. โฆSee details»
RegeneMed Inc. - TCA Venture Group
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โฆSee details»
RegeneMed - 2025 Company Profile, Funding & Competitors
Apr 15, 2025 RegeneMed - Provider of engineered human tissue-based assays for research purposes. This company is not active anymore. Raised a total funding of $1M from 1 investor. โฆSee details»
RegeneMed Company Profile | Management and Employees List
RegeneMed Profile and History. RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human โฆSee details»
RegeneMed Inc.
RegeneMed tissue technologies are off-the-shelf available, scalable, reproducible and specific and designed to provide normal, diseased and polymorphic tissues. Additional applications โฆSee details»
RegeneMed - Overview, News & Competitors | ZoomInfo.com
RegeneMed. Business Services · California, United States · <25 Employees . RegeneMed accelerates the development of safer, more effective drugs by providing integrated high โฆSee details»
RegeneMed, Inc - VentureRadar
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โฆSee details»
Regenemed Inc - Company Profile and News - Bloomberg Markets
Company profile page for Regenemed Inc including stock price, company news, executives, board members, and contact informationSee details»
RegeneMed Inc. - Contact Us
(858) 200-9530 (858) 200-9531. Dawn R. Applegate, Ph.D. Brian A. Naughton, Ph.D.See details»
Dawn Applegate - Owner - RegeneMed, Inc. | LinkedIn
Owner, RegeneMed, Inc. · Experience: RegeneMed, Inc. · Location: San Diego · 500+ connections on LinkedIn. View Dawn Applegateโs profile on LinkedIn, a professional โฆSee details»
RegeneMed Inc. โ Funding, Valuation, Investors, News | Parsers VC
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โฆSee details»
RegeneMed - Funding, Financials, Valuation & Investors
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»
RegeneMed - Contacts, Employees, Board Members, Advisors
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»
Careers | RegenMed
Careers THE COMPANY. RegenMed, headquartered in the United States and founded in 2014, develops long-term partnerships with physicians, medical associations, and product โฆSee details»
RegeneMed - CoBee Company Profile & Funding Rounds
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their โฆSee details»
RegeneMed - Crunchbase
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays. Search Crunchbase. Start Free Trial . Chrome โฆSee details»
RegeneMed - Updates, News, Events, Signals & Triggers
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»